[
  {
    "ts": "2025-12-06T05:34:19+00:00",
    "headline": "Jim Cramer on Bristol-Myers’ Recent Stock Gain: “Unbelievable”",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the stocks Jim Cramer commented on along with the recent macro rally. Cramer mentioned the stock during the episode, as he commented: “Then it might be a comeback to the drug stocks. Why? Well, remember, lots of people think the economy is stalled or in a tailspin. They’re […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-bristol-myers-recent-053419979.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "f67275bd-cac4-3854-8742-3753b9fa6def",
      "content": {
        "id": "f67275bd-cac4-3854-8742-3753b9fa6def",
        "contentType": "STORY",
        "title": "Jim Cramer on Bristol-Myers’ Recent Stock Gain: “Unbelievable”",
        "description": "",
        "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the stocks Jim Cramer commented on along with the recent macro rally. Cramer mentioned the stock during the episode, as he commented: “Then it might be a comeback to the drug stocks. Why? Well, remember, lots of people think the economy is stalled or in a tailspin. They’re […]",
        "pubDate": "2025-12-06T05:34:19Z",
        "displayTime": "2025-12-06T05:34:19Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/7b1d6a1350c79cef49b9cb2889204dd6",
          "originalWidth": 1000,
          "originalHeight": 666,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/E2lv2kKRF2jXt8F.V84xVw--~B/aD02NjY7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/7b1d6a1350c79cef49b9cb2889204dd6.cf.webp",
              "width": 1000,
              "height": 666,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BN9PfJYu5RffW4DiInJR2Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/7b1d6a1350c79cef49b9cb2889204dd6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-bristol-myers-recent-053419979.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-bristol-myers-recent-053419979.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-06T08:08:23+00:00",
    "headline": "What New Catalysts Are Shaping the Evolving Narrative for Johnson and Johnson Now",
    "summary": "Johnson & Johnson’s latest narrative has tilted more constructive, with fresh research nudging its fair value estimate higher from about $200.82 to $202.54 per share and reaffirming a roughly 6.96% discount rate that underscores a steady risk return profile. Analysts are increasingly crediting portfolio simplification and improving growth drivers for this modest fair value upgrade, suggesting the market may be slowly reassessing the stock’s long term earnings potential. Stay tuned to see how...",
    "url": "https://finance.yahoo.com/news/catalysts-shaping-evolving-narrative-johnson-080823475.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "1325566e-2b6f-3f87-ac20-7ecc67d2c104",
      "content": {
        "id": "1325566e-2b6f-3f87-ac20-7ecc67d2c104",
        "contentType": "STORY",
        "title": "What New Catalysts Are Shaping the Evolving Narrative for Johnson and Johnson Now",
        "description": "",
        "summary": "Johnson & Johnson’s latest narrative has tilted more constructive, with fresh research nudging its fair value estimate higher from about $200.82 to $202.54 per share and reaffirming a roughly 6.96% discount rate that underscores a steady risk return profile. Analysts are increasingly crediting portfolio simplification and improving growth drivers for this modest fair value upgrade, suggesting the market may be slowly reassessing the stock’s long term earnings potential. Stay tuned to see how...",
        "pubDate": "2025-12-06T08:08:23Z",
        "displayTime": "2025-12-06T08:08:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VmOStVnJjLnU3xikg4stLA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/trESudVvS0UypUeXuQ_Yww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/catalysts-shaping-evolving-narrative-johnson-080823475.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/catalysts-shaping-evolving-narrative-johnson-080823475.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]